Bio Medica Laboratories Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	117.81	97.95	26.31	3.6	-
Depreciation & Amortization	11.63	10.05	11.1	4.97	-
Loss (Gain) From Sale of Assets	0.18	-	-	-	-
Other Operating Activities	25.38	32.92	8.84	7.76	-
Change in Accounts Receivable	-65.23	-17.64	17.37	13.74	-
Change in Inventory	-179.04	-107.71	-34.65	-15.74	-
Change in Accounts Payable	-0.51	22.53	-26.38	11.82	-
Change in Other Net Operating Assets	29.44	-74.82	-10.46	-19.63	-
Operating Cash Flow	-60.35	-36.72	-7.88	6.52	-
Operating Cash Flow Growth	-	-	-	-	-
Capital Expenditures	-28.12	-0.19	-15.26	-17.1	-
Sale of Property, Plant & Equipment	1.21	0.46	-	-	-
Other Investing Activities	5.81	3.12	1.88	2.76	-
Investing Cash Flow	-21.1	3.39	-13.38	-14.34	-
Short-Term Debt Issued	20.06	73	-	-	-
Long-Term Debt Issued	84.85	-	30.95	5.51	-
Total Debt Issued	104.91	73	30.95	5.51	-
Short-Term Debt Repaid	-	-17.75	-	-	-
Long-Term Debt Repaid	-	-10.01	-	-	-
Total Debt Repaid	-	-27.76	-	-	-
Net Debt Issued (Repaid)	104.91	45.24	30.95	5.51	-
Other Financing Activities	-22.56	-11.95	-9.66	-7.74	-
Financing Cash Flow	82.35	33.29	21.29	-2.24	-
Miscellaneous Cash Flow Adjustments	-0.05	-	-	-0.01	-
Net Cash Flow	0.85	-0.04	0.04	-10.07	-
Free Cash Flow	-88.46	-36.91	-23.13	-10.58	-
Free Cash Flow Growth	-	-	-	-	-
Free Cash Flow Margin	-20.53%	-9.66%	-15.17%	-6.52%	-
Free Cash Flow Per Share	-9.72	-4.02	-2.52	-1.15	-
Levered Free Cash Flow	-129.63	-64.17	-13.73	0.13	-
Unlevered Free Cash Flow	-115.53	-55.87	-7.86	4.69	-
Cash Interest Paid	22.56	11.95	9.66	7.74	-
Cash Income Tax Paid	41.92	12.48	-	-	-
Change in Working Capital	-215.34	-177.64	-54.13	-9.81	-